Santosh Kumar Karn
Research Subjects
Research Interests
Santosh Kumar Karn has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Anne Bhambri
Department of Biotechnology, Shri Guru Ram Rai University, Dehradun, Uttarakhand, India
7 shared publicationsJizhou Duan
Key Laboratory of Environmental Corrosion and Biofouling, Institute of Oceanology , Chinese Academy of Sciences , No. 7 Nanhai Road , Qingdao , 266071 , China
4 shared publications- Awanish Kumar
Department of Biotechnology, National Institute of Technology
3 shared publications Ian R. Jenkinson
Agency for Consultation and Research in Oceanography, La Roche Canillac, France
3 shared publications- Mondem Sudhakara Reddy
Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, India
3 shared publications Moni Kumari
Department of Biochemistry & Biotechnology, Sardar Bhagwan Singh University, Dehradun, India
3 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1121-1139
Harnessing Herbal Wisdom against SARS-CoV-2: A Review of Plant-derived Antiviral Agents
Background: The COVID-19 Pandemic caused by SARS-CoV-2 has exposed a major gap in the global healthcare system. Although vaccines and synthetic antivirals are available, challenges such as emerging variants, limited accessibility, and uneven distribution persist. This has increased in medical plants as alternative therapeutic options. Aim: This study aims to evaluate the potential of plant phytochemicals as antiviral agents against SARS-CoV-2 and their role in integrative and future pandemic management strategies. Methods: Our systematic review of literature from 2020 to 2025 was included using databases such as PubMed, Web of Science, and Google Scholar. Focusing on antiviral, immunomodulatory and anti-inflammatory properties of medical plants and their bioactive compounds was analysed, including in silico, in vitro and clinical evidence. Results: Some phytochemical such as glycyrrhizin, curcumin, withanolides, andrographolide, baicalein, and resveratrol, demonstrated important antiviral potential. These compounds act through multiple mechanisms, including spike-ACE2 inhibition, RdRp suppression, protease inhibition, and cytokine storm regulation. In vitro and computational studies confirmed their efficacy, while emerging clinical evidence supports their role as adjuvant therapies. Nanocarrier systems and bioenhancers like piperine further improve their bioavailability and therapeutic effectiveness. Conclusion: Plant-based antiviral compounds are a promising and low-cost way to treat SARS-CoV-2 and other viral infections. However, challenges include standardisation, bioavailability, and regulation. Major Findings: Plant phytochemicals show multi-target antiviral activity against SARS-CoV-2 via inhibitor RdRp suppression and immunomodulation. Nanotechnology improves their efficacy, but clinical validation and standardisation are still needed.
- 30 May 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1121-1139
Open AccessHarnessing Herbal Wisdom against SARS-CoV-2: A Review of Plant-derived Antiviral Agents
Background: The COVID-19 Pandemic caused by SARS-CoV-2 has exposed a major gap in the global healthcare system. Although vaccines and synthetic antivirals are available, challenges such as emerging variants, limited accessibility, and uneven distribution persist. This has increased in medical plants as alternative therapeutic options. Aim: This study aims to evaluate the potential of plant phytochemicals as antiviral agents against SARS-CoV-2 and their role in integrative and future pandemic management strategies. Methods: Our systematic review of literature from 2020 to 2025 was included using databases such as PubMed, Web of Science, and Google Scholar. Focusing on antiviral, immunomodulatory and anti-inflammatory properties of medical plants and their bioactive compounds was analysed, including in silico, in vitro and clinical evidence. Results: Some phytochemical such as glycyrrhizin, curcumin, withanolides, andrographolide, baicalein, and resveratrol, demonstrated important antiviral potential. These compounds act through multiple mechanisms, including spike-ACE2 inhibition, RdRp suppression, protease inhibition, and cytokine storm regulation. In vitro and computational studies confirmed their efficacy, while emerging clinical evidence supports their role as adjuvant therapies. Nanocarrier systems and bioenhancers like piperine further improve their bioavailability and therapeutic effectiveness. Conclusion: Plant-based antiviral compounds are a promising and low-cost way to treat SARS-CoV-2 and other viral infections. However, challenges include standardisation, bioavailability, and regulation. Major Findings: Plant phytochemicals show multi-target antiviral activity against SARS-CoV-2 via inhibitor RdRp suppression and immunomodulation. Nanotechnology improves their efficacy, but clinical validation and standardisation are still needed.
- 23 March 2026
- Published by SAGE Publications in Industrial Biotechnology
- Vol. 22 (2) , 166-180
Lysine Oxidase: An Enzyme to Control Biofilm, Survey, and Analysis
Biofilms consist of complex three-dimensional structures produced by fungi and bacteria at interfaces and are considered a severe hazard to human health. The biofilm formed on the surface of medical instruments leads to a major threat of dispersing microorganisms within the host and causing infection through the release of both single and clustered cells. The removal of biofilms is very challenging because of their resistance to antimicrobial therapies and high tolerance toward conventional antimicrobial agents. Therefore, it is necessary to treat biofilms more effectively and also important to understand the mechanism for biofilm formation. Addressing this key issue, this review begins with an outline of the process of biofilm formation and the associated therapeutic strategies, emphasizing the role of lysine oxidase in developing innovative antibiofilm materials for inhibiting and removing biofilms. Amino acid oxidases such as lysine oxidase and escapin are highlighted for their ability to produce hydrogen peroxide (H 2 O 2 ), which exhibits antimicrobial properties against both planktonic bacteria and biofilm. It was demonstrated that the combined use of escapin intermediate products (EIP) and H 2 O 2 can prevent biofilm formation and disrupt established biofilms at micromolar concentrations by using an organism, Pseudomonas aeruginosa , as an experimental model. In addition was also observed the antifungal activity of lysine and the effects of poly-L-lysine (pLK) on bacterial biofilms. In Marinomonas mediterranea , the lysine oxidase AlpP homologue (LodA) mediates bacterial growth inhibition, DNA strand breakage, lipid peroxidation, and cell death through the accumulation of reactive species such as H 2 O 2 . Lysine alone lacked fungicidal activity, but it amplified the action of amphotericin B against C.andida albicans by inhibiting biofilm and hypha formation. Furthermore, pLK showed antimicrobial properties due to its cationic charges, effective against pathogens, including P. aeruginosa and Staphylococcus aureus . The review also includes the potential of synthetic mimics of antimicrobial peptides over natural peptides, which provide better stability and cost-effectiveness for treating biofilms associated with both ventilator-associated pneumonia and cystic fibrosis.
- 23 March 2026
- Published by SAGE Publications in Industrial Biotechnology
- Vol. 22 (2) , 166-180
Lysine Oxidase: An Enzyme to Control Biofilm, Survey, and Analysis
Biofilms consist of complex three-dimensional structures produced by fungi and bacteria at interfaces and are considered a severe hazard to human health. The biofilm formed on the surface of medical instruments leads to a major threat of dispersing microorganisms within the host and causing infection through the release of both single and clustered cells. The removal of biofilms is very challenging because of their resistance to antimicrobial therapies and high tolerance toward conventional antimicrobial agents. Therefore, it is necessary to treat biofilms more effectively and also important to understand the mechanism for biofilm formation. Addressing this key issue, this review begins with an outline of the process of biofilm formation and the associated therapeutic strategies, emphasizing the role of lysine oxidase in developing innovative antibiofilm materials for inhibiting and removing biofilms. Amino acid oxidases such as lysine oxidase and escapin are highlighted for their ability to produce hydrogen peroxide (H 2 O 2 ), which exhibits antimicrobial properties against both planktonic bacteria and biofilm. It was demonstrated that the combined use of escapin intermediate products (EIP) and H 2 O 2 can prevent biofilm formation and disrupt established biofilms at micromolar concentrations by using an organism, Pseudomonas aeruginosa , as an experimental model. In addition was also observed the antifungal activity of lysine and the effects of poly-L-lysine (pLK) on bacterial biofilms. In Marinomonas mediterranea , the lysine oxidase AlpP homologue (LodA) mediates bacterial growth inhibition, DNA strand breakage, lipid peroxidation, and cell death through the accumulation of reactive species such as H 2 O 2 . Lysine alone lacked fungicidal activity, but it amplified the action of amphotericin B against C.andida albicans by inhibiting biofilm and hypha formation. Furthermore, pLK showed antimicrobial properties due to its cationic charges, effective against pathogens, including P. aeruginosa and Staphylococcus aureus . The review also includes the potential of synthetic mimics of antimicrobial peptides over natural peptides, which provide better stability and cost-effectiveness for treating biofilms associated with both ventilator-associated pneumonia and cystic fibrosis.
- Open Access
- 1 January 2026
- Published by Wiley in Aquaculture Nutrition
- Vol. 2026 (1) , 5390688
Combined Dietary Effects of Tenebrio molitor Meal and Probiotics on Growth Performance, Immune Response, and Pathogen Resistance in Nile Tilapia ( Oreochromis niloticus )
The prospective utilization of insects as alternative protein sources to replace fishmeal (FM) in aquafeed has prompted increased interest. This study evaluated the effects of yellow mealworm Tenebrio molitor (TML)‐based diet supplemented with 2% mixed probiotics on growth performance and resistance to Aeromonas hydrophila infection in Nile tilapia ( Oreochromis niloticus ). Six experimental diets were formulated. The control group (CTRL) received commercial feed containing 30% FM. In the experimental groups (T25P + , T50P + , and T100P + ), FM was replaced with TML at inclusion rates of 25%, 50%, and 100%, respectively. The T50P – group was identical to the T50P + group but lacked probiotics, whereas the CTRLP + group received the control diet (without TML) supplemented with 2% probiotics. Juvenile tilapia weighing 12.81 ± 1.37 g were fed the respective diets for 8 weeks. By the end of the feeding trial, fish receiving the T50P + diet exhibited superior overall performance, characterized by a significantly higher weight gain (WG; 91%) and survival rate (98%) compared with the CTRL ( p < 0.05). This group also demonstrated markedly enhanced digestive enzyme activities, including protease (30.5–34.7 U/mg), lipase (18.2–22.6 U/mg), and amylase (20.8–23.5 U/mg), alongside elevated lysozyme activity, improved antioxidant capacity, and stronger bactericidal activity. Although the T100P + diet led to improvements in several parameters relative to the control, its overall performance remained inferior to that of the T50P + group, indicating that partial replacement of FM was more effective than complete substitution. Furthermore, fish fed the T50P + diet displayed enhanced fillet quality, evidenced by higher crude protein (CP) content (59.63%) and a moderate lipid level (29.73%). Following challenge with Aeromonas hydrophila , the T50P + group showed a substantially reduced mortality rate (20%) compared with the CTRL (80%), confirming a pronounced improvement in disease resistance. Overall, the results suggest that replacing 50% of FM with TML in combination with probiotics enhances growth, nutrient utilization, immune function, and pathogen resistance in Nile tilapia. This TML–probiotic formulation represents a promising, sustainable, and effective alternative to conventional aquafeeds.
- 1 January 2026
- Published by Wiley in Aquaculture Nutrition
- Vol. 2026 (1) , 5390688
Open AccessCombined Dietary Effects of Tenebrio molitor Meal and Probiotics on Growth Performance, Immune Response, and Pathogen Resistance in Nile Tilapia ( Oreochromis niloticus )
The prospective utilization of insects as alternative protein sources to replace fishmeal (FM) in aquafeed has prompted increased interest. This study evaluated the effects of yellow mealworm Tenebrio molitor (TML)‐based diet supplemented with 2% mixed probiotics on growth performance and resistance to Aeromonas hydrophila infection in Nile tilapia ( Oreochromis niloticus ). Six experimental diets were formulated. The control group (CTRL) received commercial feed containing 30% FM. In the experimental groups (T25P + , T50P + , and T100P + ), FM was replaced with TML at inclusion rates of 25%, 50%, and 100%, respectively. The T50P – group was identical to the T50P + group but lacked probiotics, whereas the CTRLP + group received the control diet (without TML) supplemented with 2% probiotics. Juvenile tilapia weighing 12.81 ± 1.37 g were fed the respective diets for 8 weeks. By the end of the feeding trial, fish receiving the T50P + diet exhibited superior overall performance, characterized by a significantly higher weight gain (WG; 91%) and survival rate (98%) compared with the CTRL ( p < 0.05). This group also demonstrated markedly enhanced digestive enzyme activities, including protease (30.5–34.7 U/mg), lipase (18.2–22.6 U/mg), and amylase (20.8–23.5 U/mg), alongside elevated lysozyme activity, improved antioxidant capacity, and stronger bactericidal activity. Although the T100P + diet led to improvements in several parameters relative to the control, its overall performance remained inferior to that of the T50P + group, indicating that partial replacement of FM was more effective than complete substitution. Furthermore, fish fed the T50P + diet displayed enhanced fillet quality, evidenced by higher crude protein (CP) content (59.63%) and a moderate lipid level (29.73%). Following challenge with Aeromonas hydrophila , the T50P + group showed a substantially reduced mortality rate (20%) compared with the CTRL (80%), confirming a pronounced improvement in disease resistance. Overall, the results suggest that replacing 50% of FM with TML in combination with probiotics enhances growth, nutrient utilization, immune function, and pathogen resistance in Nile tilapia. This TML–probiotic formulation represents a promising, sustainable, and effective alternative to conventional aquafeeds.
- 12 March 2025
- Published by Springer Nature
- p. 143-154
Impact of Microplastics on the Environment, Human Health and Their Removal
- 12 March 2025
- Published by Springer Nature
- p. 143-154
Impact of Microplastics on the Environment, Human Health and Their Removal
- 6 March 2025
- Published by Springer Nature in Biodegradation
- Vol. 36 (2) , 1-25
Biochar mediated fixation of nitrogen compounds (ammonia and nitrite) in soil: a review
Biochar (BC) is a carbon-rich material created from biomass pyrolysis. It is an efficient addition for reducing ammonia inhibition due to its large specific surface area, porosity, conductivity, redox characteristics, and functional groups making it favorable for both soil and water remediation. The efficacy of biochar on the N cycle is associated with biochar properties which are mainly affected by feedstock type and pyrolysis condition. The addition of BC to soil affects nitrogen adsorption pathways. Other advantages include improved soil fertility, nutrient immobilization, and slow-release carbon storage. Biochar adsorption of ammonia reduces ammonia (NH3) and nitrate (NO3) losses during composting after manure applications and provides a method for creating slow-release fertilizers. Depending on the N source and the properties of the biochar, NH3 loss reductions vary. Besides improving soil dynamics, BC can also be used in wastewater treatment. Engineered or designer biochar is positioned as a promising material for wastewater treatment due to its enhanced properties and versatility.
- 6 March 2025
- Published by Springer Nature in Biodegradation
- Vol. 36 (2) , 1-25
Biochar mediated fixation of nitrogen compounds (ammonia and nitrite) in soil: a review
Biochar (BC) is a carbon-rich material created from biomass pyrolysis. It is an efficient addition for reducing ammonia inhibition due to its large specific surface area, porosity, conductivity, redox characteristics, and functional groups making it favorable for both soil and water remediation. The efficacy of biochar on the N cycle is associated with biochar properties which are mainly affected by feedstock type and pyrolysis condition. The addition of BC to soil affects nitrogen adsorption pathways. Other advantages include improved soil fertility, nutrient immobilization, and slow-release carbon storage. Biochar adsorption of ammonia reduces ammonia (NH3) and nitrate (NO3) losses during composting after manure applications and provides a method for creating slow-release fertilizers. Depending on the N source and the properties of the biochar, NH3 loss reductions vary. Besides improving soil dynamics, BC can also be used in wastewater treatment. Engineered or designer biochar is positioned as a promising material for wastewater treatment due to its enhanced properties and versatility.
- Open Access
- 11 June 2024
- Published by Frontiers Media SA in Frontiers in Fungal Biology
- Vol. 5, 1414349
Submerged cultivation and phytochemical analysis of medicinal mushrooms (Trametes sp.)
Mushrooms are widely available around the world and have various nutritional as well as therapeutic values. Many Asian cultures believe that medicinal mushrooms can prolong life and improve vitality. This study aims to characterize the phytochemical and polysaccharide content, mainly β-glucan content, of mycelial biomass and fruiting bodies collected from the Himalayan region, particularly Uttarakhand. Through molecular analysis of the LSU F/R-rDNA fragment sequence and phylogenetic analysis, the strain was identified as Trametes sp. We performed screening of phytochemicals and polysaccharides in mushroom and biomass extracts using high-performance liquid chromatography (HPLC) and a PC-based UV-Vis spectrophotometer. The macrofungal biomass was found to be high in saponin, anthraquinone, total phenolic, flavonoid, and β-glucan content. In biomass extract, we observed a high level of saponin (70.6µg/mL), anthraquinone (14.5µg/mL), total phenolic (12.45 µg/mL), and flavonoid (9.500 µg/mL) content. Furthermore, we examined the contents of alkaloids, tannins, terpenoids, and sterols in the biomass and mushroom extracts; the concentration of these compounds in the ethanol extract tested was minimal. We also looked for antioxidant activity, which is determined in terms of the IC50 value. Trametes sp. mushroom extract exhibits higher DPPH radical scavenging activity (62.9% at 0.5 mg/mL) than biomass extract (59.19% at 0.5 mg/mL). We also analyzed β-glucan in Trametes sp. from both mushroom and biomass extracts. The biomass extract showed a higher β-glucan content of 1.713 mg/mL than the mushroom extract, which is 1.671 mg/mL. Furthermore, β-glucan analysis was confirmed by the Megazyme β-glucan assay kit from both biomass and mushroom extract of Trametes sp. β-glucans have a promising future in cancer treatment as adjuncts to conventional medicines. Producing pure β-glucans for the market is challenging because 90–95% of β glucan sold nowadays is thought to be manipulated or counterfeit. The present study supports the recommendation of Trametes sp. as rich in β-glucan, protein, phytochemicals, and antioxidant activities that help individuals with cancer, diabetes, obesity, etc.
- 11 June 2024
- Published by Frontiers Media SA in Frontiers in Fungal Biology
- Vol. 5, 1414349
Open AccessSubmerged cultivation and phytochemical analysis of medicinal mushrooms (Trametes sp.)
Mushrooms are widely available around the world and have various nutritional as well as therapeutic values. Many Asian cultures believe that medicinal mushrooms can prolong life and improve vitality. This study aims to characterize the phytochemical and polysaccharide content, mainly β-glucan content, of mycelial biomass and fruiting bodies collected from the Himalayan region, particularly Uttarakhand. Through molecular analysis of the LSU F/R-rDNA fragment sequence and phylogenetic analysis, the strain was identified as Trametes sp. We performed screening of phytochemicals and polysaccharides in mushroom and biomass extracts using high-performance liquid chromatography (HPLC) and a PC-based UV-Vis spectrophotometer. The macrofungal biomass was found to be high in saponin, anthraquinone, total phenolic, flavonoid, and β-glucan content. In biomass extract, we observed a high level of saponin (70.6µg/mL), anthraquinone (14.5µg/mL), total phenolic (12.45 µg/mL), and flavonoid (9.500 µg/mL) content. Furthermore, we examined the contents of alkaloids, tannins, terpenoids, and sterols in the biomass and mushroom extracts; the concentration of these compounds in the ethanol extract tested was minimal. We also looked for antioxidant activity, which is determined in terms of the IC50 value. Trametes sp. mushroom extract exhibits higher DPPH radical scavenging activity (62.9% at 0.5 mg/mL) than biomass extract (59.19% at 0.5 mg/mL). We also analyzed β-glucan in Trametes sp. from both mushroom and biomass extracts. The biomass extract showed a higher β-glucan content of 1.713 mg/mL than the mushroom extract, which is 1.671 mg/mL. Furthermore, β-glucan analysis was confirmed by the Megazyme β-glucan assay kit from both biomass and mushroom extract of Trametes sp. β-glucans have a promising future in cancer treatment as adjuncts to conventional medicines. Producing pure β-glucans for the market is challenging because 90–95% of β glucan sold nowadays is thought to be manipulated or counterfeit. The present study supports the recommendation of Trametes sp. as rich in β-glucan, protein, phytochemicals, and antioxidant activities that help individuals with cancer, diabetes, obesity, etc.
- Open Access
- 20 May 2024
- Published by Frontiers Media SA in Frontiers in Environmental Science
- Vol. 12, 1390660
Role of the sea surface biofilm in regulating the Earth’s climate
Role of the sea surface biofilm in regulating the Earth’s climate
- 20 May 2024
- Published by Frontiers Media SA in Frontiers in Environmental Science
- Vol. 12, 1390660
Open AccessRole of the sea surface biofilm in regulating the Earth’s climate
Role of the sea surface biofilm in regulating the Earth’s climate
- 29 March 2024
- Published by Springer Nature
- p. 633-644
Global Status of Microbial Engineering for Biofuel Production - Advances, Challenges, and Roadmap
- 29 March 2024
- Published by Springer Nature
- p. 633-644
Global Status of Microbial Engineering for Biofuel Production - Advances, Challenges, and Roadmap
- 13 February 2024
- Published by Springer Nature
- p. 117-135
The Effects of Mercury Exposure on Neurological and Cognitive Dysfunction in Human: A Review
- 13 February 2024
- Published by Springer Nature
- p. 117-135
The Effects of Mercury Exposure on Neurological and Cognitive Dysfunction in Human: A Review
- 1 December 2023
- Published by Springer Nature
- p. 185-198
Chemicals Used in Agriculture: Hazards and Associated Toxicity Issues
- 1 December 2023
- Published by Springer Nature
- p. 185-198
Chemicals Used in Agriculture: Hazards and Associated Toxicity Issues